NEXT
BING NEWS:
  • Drugmaker AbbVie expects Humira volume erosion to worsen
    roughly in line with estimates of $2.28 billion. The drugmaker and its investors have focused on sales of Skyrizi and Rinvoq to offset the erosion of sales from Humira. The company earlier on ...
    04/26/2024 - 10:12 am | View Link
  • Why AbbVie Stock Stumbled Today Despite the Earnings Beat
    The analysts' consensus estimates had only called for a profit of $2.23 per share on revenue of $11.9 billion. The drugmaker now anticipates ... for investors to buy now… and AbbVie wasn ...
    04/26/2024 - 9:07 am | View Link
  • AbbVie Q1 report beats Street despite plunging Humira sales
    Shares of AbbVie (NYSE:ABBV) slid nearly 4% in morning trading Friday, despite the drugmaker reporting better-than-expected Q1 earnings and raising its adjusted 2024 EPS forecast. Early Friday ...
    04/26/2024 - 5:20 am | View Link
  • Drugmaker AbbVie expects Humira volume erosion to worsen
    (Reuters) -AbbVie expects a drop in sales volumes of its blockbuster arthritis drug Humira to deepen after recent changes by U.S. pharmacy benefit managers and as patients shift to other drugs.
    04/26/2024 - 1:30 am | View Link
  • AbbVie's first-quarter results top expectations as arthritis drugs fuel growth
    The drugmaker reported first-quarter net income of $1.369 billion, or 77 cents per share, versus $239 million, or 13 cents per share, in the year-earlier period. Adjusted earnings per share of $2. ...
    04/26/2024 - 1:18 am | View Link
  • More

 

NEXT
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

Movies With Butter More Movie News

More Business News